Market Overview

ResMed Wins Patent Fight Against APEX

A U.S. government investigation started at the request of ResMed (NYSE: RMD) against Taiwanese manufacturer APEX Medical Corp. has resulted in an administrative law judge at the International Trade Commission (ITC) determining that the ITC should enter a consent decree against APEX stopping the importation and sale of infringing APEX products.

The ITC case against APEX also named Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing (Drive). The same ITC administrative law judge previously determined that the ITC should enter a consent decree against Drive thereby ordering it to stop importation and sales of the Freedom 210 and Freedom 220 masks made by APEX, which are identical to the WiZARD masks. 

See full press release

Posted-In: News Guidance Contracts Management M&A Global

 

Most Popular

Related Articles (RMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free